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OBJECTIVES This study was designed to identify possible electrical remodeling (ER) in transgenic (Tg)
mice with over-expressed L-type Ca2 channels. Transient outward K current (Ito) and
action potential duration (APD) were studied in 2-, 4-, 8-, and 9- to 12-month-old mice to
determine linkage to ventricular remodeling (VR), ER, and heart failure (HF).
BACKGROUND Prolongation of APD and reduction in current density of Ito are thought to be hallmarks of
VR and HF. Mechanisms are not understood.
METHODS Patch-clamp, perfused hearts, echocardiography, and Western blots were employed using 2-,
4-, 8-, and 9- to 12-month-old Tg mice.
RESULTS Transgenic mice developed slow VR statistically manifesting at four months and continuing
through death at 12 to 14 months, despite a slight up-regulation of Ito. A slight decrease or
no change in APD was observed up to eight months; however, at 9 to 12 months, a small
increase in APD was detected. Early afterdepolarizations were observed after application of
4-aminopyridine in Tg mice. No change was detected in protein of Kv4.3 and Kv4.2 up to
eight months. At 9 to 12 months, Tg mice showed a slight decrease (41.4  6.9%, p  0.05) in
Kv4.2, consistent with a decrease in Ito. Surprisingly, Kv1.4 (the “fetal” K
-channel form) was
up-regulated, and restitution of Ito was slowed. Echocardiography revealed cardiac enlargement
with impaired chamber function in hearts that were taken from the older animals.
CONCLUSIONS Contrary to accepted dogma, APD and Ito in a mouse model of hypertrophy and HF are not
hallmarks of pathophysiology. We suggest that [Ca2]i (i.e., [Ca
2] concentration) is the
primary factor in triggering cardiac enlargement and arrhythmogenesis. (J Am Coll Cardiol
2003;41:1611–22) © 2003 by the American College of Cardiology Foundation
It is well known that Ca2 homeostasis is vital in maintain-
ing adequate regulation of the heart. When Ca2 handling
becomes dysfunctional, as is the case when proteins that
regulate intracellular calcium are over-expressed or
“knocked out” in transgenic animals (Tg), pathophysiologic
changes ensue. For example, Tg mouse lines with targeted
over-expression of cardio-specific calsequestrin (1), cal-
cineurin (2), Ca2/calmodulin-dependent protein
kinase-IV (3), Gs(4), and Gq (5) develop cardiac hyper-
trophy and, eventually, heart failure (HF) as the animals
age. The anatomic process of hypertrophy is generally
referred to as “ventricular remodeling.” The latter is fre-
quently accompanied by arrhythmogenic changes known as
“electrical remodeling.” The latter typically is thought to
include prolongation of action potential duration (APD),
down-regulation of transient outward potassium current
(Ito), and inward rectifier potassium current (IK1), decreased
responsiveness to -adrenergic stimulation, and alterations
of intracellular Ca2 handling. Gwathmey et al. (6) were the
first to show prolongation of the Ca2 signal and APD in
trabeculae from failing human myocardium. Despite com-
pelling evidence to implicate that Ito is a key contributor in
the repolarization process of the ventricular action potential
(7), the role of Ito in the APD remains unclear. The changes
in Ito that have been reported in hypertrophy and subse-
quent to myocardial infarction and HF are equivocal.
Down-regulation of Ito has been described in a number of
rat models of myocardial hypertrophy (8) and in human HF
(9). In Tg mouse models of HF where Gq (5) or
calsequestrin is over-expressed (1), a marked down-
regulation of Ito density appears to be associated with a
prolongation of the APD. On the other hand, there are
reports of an “up-regulation” of Ito in hypertrophied cardiac
myocytes (10–12) and in cardiac myocytes after induced
myocardial infarction (13). Taken together, cellular hyper-
trophy is not always linked to a reduction in Ito. The
complexities of K-associated currents and the APD, as
well as difficulties in trying to “link” Ito and APD, have
recently been nicely discussed by Roden (14). On the other
hand, most investigators, perhaps more intuitively than
factually, feel that increases in intracellular Ca2 concentra-
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tion ([Ca2]i) may lead to contractile dysfunction, hyper-
trophy, and HF (15) and that [Ca2]i increases may trigger
downstream signaling cascades that initiate a “hypertrophic
gene program” (16). Enhanced Ca2 entry can extend the
plateau phase of the action potential, thereby increasing the
APD that, in turn, would at least theoretically result in
elevated [Ca2]i, causing hypercontractility of an already
compromised heart and arrhythmias at the onset of cardiac
hypertrophy; Ca2 entering through the L-type voltage-
dependent calcium channel (L-VDCC) not only serves as a
trigger for contraction but also may transduce the electrical
signals into a series of biochemical signals in the heart.
Backx et al. (17) supported this hypothesis in mice over-
expressing an N-terminal fragment of Kv4.2, by showing
that verapamil treatment prevented the progressively devel-
oped cardiomyopathy. The specific role of altered L-type Ca2
channels in the impaired Ca2 homeostasis of the failing heart
(1,5,18,19) is an area of considerable controversy.
We generated Tg mice, over-expressing the cardiac 1
subunit of the L-VDCC (20) in order to simulate a scenario
in which there would be a sustained but low-level of an
increased intracellular calcium. These animals exhibited a
slowly developing hypertrophy and eventually died with a
cardiomyopathic HF phenotype (21). We hypothesize that
a sustained increase of inward calcium current (ICa) (22,23),
regardless of the source, is a major important mediator of
hypertrophy associated with electrical remodeling. We stud-
ied these mice in order to reveal the underlying electrophysi-
ologic basis of the electrical remodeling. Accordingly, the
present study was designed to systematically characterize the
electrophysiologic properties (Ito and APD) of cardiac
myocytes derived during aging in these Tg mice in order to
determine if there is a consistent pattern of ion current
changes in both ventricular and electrical remodeling. In
this study, we report in vivo, in situ, and cellular evidence
that Ca2 is the critical signal of cardiac hypertrophy and
that the APD and Ito are hallmarks of the electrical, but not
the ventricular, remodeling processes.
METHODS
Isolation of ventricular myocytes and electrophysiology.
Cardiac ventricular myocytes isolation from 2-, 4-, 8-, and
9- to 12-month-old Tg and nontransgenic (Ntg) mice,
whole cell voltage- and current-clamp recording methods,
and data analysis were identical to those previously de-
scribed by us (18,20). In the studies to determine recovery of
Ito from inactivation, a double pulse protocol was used. Two
depolarizing pulses (from 80 mV to 40 mV, 300-ms
long) with a varying interpulse interval (from 20 ms to 3,000
ms) were applied every 10 s. The rapidly inactivating current
is referred to as Ito,fast, and the slowly inactivating current is
termed Ito,slow (10); Ito is defined as the difference between
the peak outward current (Ito,peak) and the Isus (the current
remaining at the end of the 680 ms pulse for the same cells).
All current amplitudes were normalized to the cell mem-
brane capacitance (Cm) and expressed as densities (pA/pF).
The experiments were carried out at room temperature (22
to 24°C).
Western blot analysis. Membrane fractions were prepared
from mouse hearts as previously described (21). Protein sam-
ples were separated on SDS-PAGE, transferred to nitrocellu-
lose membranes, and blocked in TBS-5% milk. Primary
antibodies were incubated overnight at 4°C (anti-Kv1.4
ALOMONE, anti-Kv4.2, and Kv4.3; Chemicon Int.). Sec-
ondary antibodies were peroxidase-labeled anti-rabbit or anti-
mouse IgG (Amersham). Antibody signals were detected by
enhanced chemiluminescence and quantified by densitometry
(Alpha Imager 2000, version 3.1; Alpha Innotech Corp.). All
measurements were normalized to protein levels of mouse
anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
monoclonal antibody (Chemicon Int.).
Ex vivo hemodynamic measurements. The hearts were
perfused in a retrograde manner at a constant coronary
pressure (50 mm Hg) with oxygenated Krebs-Henseleit
Buffer (37.4°C) in 9- to 12-month-old animals and in
work-performing heart preparations in younger animals as
previously described (23).
Echocardiography. In vivo ventricular function was mea-
sured with a noninvasive technique as previously described
(24). Noninvasive echocardiography was performed in 1-
over-expressed Tg and Ntg mice at ages of four and eight
months. Noninvasive cardiac function was assessed by
two-dimensional guided M-mode echocardiography.
Abbreviations and Acronyms
APD90 or APD50  action potential duration at 90%
and 50% repolarization
Cm  cell membrane capacitance
EAD  early afterdepolarization
EP  electrophysiology
HF  heart failure
ICa  L-type calcium current
IK1  inward rectifier potassium current
Isus  the current remaining at the end of
the 680 ms pulse
Ito  transient outward potassium current
(Ito,peak  Isus)
Ito,fast  rapidly inactivating and rapidly
recovering component of Ito
Ito,peak  peak transient outward potassium
current
Ito,slow  slowly inactivating and slowly
recovering component of Ito
L-VDCC  L-type voltage-dependent calcium
channel
NCX  Na-Ca2 exchanger
Ntg  nontransgenic
Tg  transgenic
fast  fast time constant of Ito inactivation
or Ito recovery from inactivation
slow  slow time constant of Ito
inactivation or Ito recovery from
inactivation
%FS  percentage fractional shortening
4-AP  4-aminopyridine
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Figure 1. Differences in the action potential (AP) shape and duration in nontransgenic (Ntg) and transgenic (Tg) myocytes. Representative APs were
recorded in single ventricular myocytes isolated from Ntg (2- and 8-month-old) and Tg mice (2-, 4-, 8-, and 9- to 12-month-old) (A). Effect of
4-aminopyridine (4-AP) on AP duration (B and C). Examples of AP recordings from mouse cardiomyocytes derived from eight-month-old Ntg (B) and
Tg (C) mice before and after application of 250 M 4-AP and washout.
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Statistical analysis. Comparison between gene expression
levels were made using unpaired Student t test or two-way
analysis of variance (followed by Bonferroni’s method for
post-hoc pairwise multiple comparisons) for electrophysiol-
ogy (EP) data to account for differences between individual
animals and individual cells. Values are expressed as mean
SEM and considered significantly different at p  0.05.
Samples sizes (n) are listed as n  x/y to denote x cells from
y mice; only one measurement per cell was performed.
RESULTS
Electrophysiologic studies. APD. Action potentials re-
corded in Ntg and Tg ventricular myocytes electrically
paced at 1 Hz (Fig. 1A, Table 1) were typically short
(spiked) in Ntg cells, that is, no evidence of a “plateau”
phase. The APD did not change significantly in Tg cells up
to eight months of age. However, in older Tg animals (9 to
12 months), the average APD at 50% repolarization
(APD50) and APD90 values were prolonged significantly
compared with their age-matched Ntg counterparts. De-
spite the changes in APDs, the resting potential did not
differ between the two groups.
Transgenic cardiac myocytes (eight-month-old) demon-
strated a higher sensitivity of the APD90 after exposure to
4-aminopyridine (4-AP) (Figs. 1B and 1C). We recorded
very long APDs in 12 of 20 cardiac myocytes derived from
six Tg mice after the application of 250 M 4-AP. The
original recordings (Fig. 1C) illustrate that Tg myocytes
after 4-AP developed early afterdepolarizations (EAD) and
failed to repolarize. Figure 1C, shows five normal APs and
five incidents of EADs. In this study, we could not record
incidence of EADs from Ntg cardiomyocytes (n  16/5).
Potassium currents. Subsequent experiments were de-
signed to examine K currents. The IK1 is important in
maintaining the resting membrane potential and in shaping
the contour of the AP (Figs. 2A to 2D). We found no
significant differences between the groups in IK1 current-
voltage relationships up to nine months of age over a broad
range of membrane potentials, particularly at the membrane
potential range encountered during phase III repolarization
of the AP, that is, from 40 mV to 80 mV. Despite the
decrease in the density of IK1 after nine months in the Tg
mice, the resting membrane potential was not significantly
altered (Tables 1 and 2).
Cell membrane capacitance (Cm) of ventricular myocytes
was indistinguishable in two-month-old cardiac myocytes.
Massive cardiac enlargement occurred at the 9- to 12-
month time period with a significant increase in Cm of Tg
myocytes (184.3  9.2 pF, Ntg, n  28/6 vs. 262.7  9.2
pF, Tg, n  45/6, p  0.05) (Table 2), which contained
large pleomorphic nuclei not observed in the Ntg myocytes.
We then investigated whether changes in the APD were
associated with alterations in Ito, as has been suggested (7).
The current-voltage relationships for Ito,peak and Ito are
illustrated in Figures 3A and 3B. In both Ntg and Tg cells,
the threshold for the activation of Ito was about 20 mV.
The Ito in the Tg cells was significantly higher in all age
groups except in the 9- to 12-month-old Tg compared with
the Ntg cells (Table 2). Similar to Ito,peak density, the Isus,
was also significantly higher than Ntg in the two-, four-,
and eight-month Tg myocytes at membrane voltages of 30
to 80 mV. The Isus density remained the same as in the Ntg
myocytes in the 9- to 12-month-old mice. It is conceivable
that with progression to hypertrophy and HF, a decrease in
the density of the Isus occurs (Figs. 3D to 3F, Table 2).
Steady-state inactivation curves were obtained in the Ntg
and Tg myocytes to compare the availability of Ito channels
for activation and to determine whether the observed
changes in current density are associated with altered
channel kinetics. Under these conditions, the residual
steady-state current was approximately 50% of the peak
current level (Fig. 4A). The mean values of V0.5 and k for
the Ntg and the Tg cells were evaluated in presence of 0.3
mM CdCl2. No significant difference was observed in V0.5
between the Ntg and Tg cells at 4- and 9- to 12-month age
groups (Table 2). We previously considered whether
changes in the availability of Ca2 channels could account
for the increased ICa (21,22); therefore, in addition, we
analyzed the steady-state inactivation characteristics of ICa
shown in Figure 4B and Table 2.
We next compared the time course of the decay phase of
Ito, which has been shown to be largely independent of
voltage, in the 4- and 9- to 12-month-old Ntg and Tg
cardiac myocytes. At 40 mV test potentials, there were
significant differences in time course of fast inactivation
(fast) between the Ntg and Tg cells in the four-month-old
age group (Ntg, 30.9 1.2 ms, n 27/4 vs. Tg, 36.2 0.7
ms, n  37/4, p  0.05). The slow was not significantly
different between Ntg and Tg mice at this age. In contrast,
slow was significantly increased in myocytes from 9- to
12-month-old Tg mice at 40 mV (Ntg, 580.8  80.3 ms,
n27/5, vs. Tg, 938.7 123.5 ms, n 30/5) (Figs. 4C and
Table 1. Action Potential Characteristics Recorded From Ntg and Tg Cardiomyocytes at Different Age Groups
2 Months 4 Months 8 Months 9–12 Months
Ntg, n  9 Tg, n  8 Ntg, n  14 Tg, n  14 Ntg, n  37 Tg, n  42 Ntg, n  16 Tg, n  17
APD50 (ms) 9.3  0.4 10.9  1.1 10.5  0.6 9.7  0.5 10.5  0.4 10.2  0.4 8.9  0.3 11.1  0.4*
APD90 (ms) 21.8  1.9 20.9  3.3 21.8  2.4 18.8  2.4 21.5  1.6 22.1  0.8 17.8  1.9 27.8  3.3*
RP (-mV) 73.8  0.7 72.3  0.7 72.5  0.4 73.2  0.6 73.4  0.4 72.4  0.5 76.5  0.8 75.9  0.7
*p  0.05.
APD50, APD90  action potential duration at 50% and 90% repolarization; Ntg  nontransgenic; RP  resting potential; Tg  transgenic.
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Figure 2. Comparison of IK1 in nontransgenic (Ntg) and trangenic (Tg) animals. Averaged peak current density-voltage relation plotted for cells from 2-,
4-, 8-, and 9- to 12-month-old Ntg and Tg mice, respectively (A). Families of representative current traces elicited from a holding potential of 40 mV
using voltage steps of 500 ms from 140 mV to 100 mV in 20 mV increments (B) from Ntg (C) as compared with Tg (D) myocyte.
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4D). The slowed inactivation kinetics of Ito suggested
differences in recovery from inactivation, prompting the
study of restitution of Ito. The recovery from inactivation of
Ito in Ntg and Tg mouse cardiac myocytes was displayed in
Figures 4E and 4F, respectively. The slow at 80 mV is
237.9  16.2 ms, n  14/3, in the Ntg was significantly
shorter than that in the Tg group, 491.2  34.8 ms, n 
36/4, p  0.001 (Table 2).
Western blot analysis was performed to see whether the
changes in Ito density could be correlated with quantitative
changes in the K channel protein expression. Interestingly,
the Kv1.4 protein was up-regulated in the eight-month-old
mice (Figs. 5A and 5B). The increase in Kv1.4 coincided
with the increase of the slow of recovery from inactivation.
In spite of this up-regulation, Kv4.3 protein levels were not
altered in the two-, four-, and eight-month-old Tg mice
(Fig. 5A, middle panel). Densitometric analysis of Kv4.2
from 9- to 12-month-old Tg mice revealed a decrease 41.4
 6.9% (n  3, p  0.05) compared with Ntg. This
observation is consistent with the EP data on Ito (Fig. 3)
indicating a 34% decrease.
Hemodynamic study. The induced hypertrophy in the Tg
mice is compensated in the first six to eight months (Table
3) of life but then progresses into frank HF. Our hemody-
namic measurements in Tg animals bear this out. In fact,
hearts taken from the 9- to 12-month-old Tg animals could
not sustain a working mode, and, even in the Langendorff
mode, these hearts revealed a very low basal contractility and
deteriorated rapidly.
Echocardiography. At four months, Tg mice showed a
mild reduction in percentage fractional shortening (%FS)
and heart rate, but other parameters did not change signif-
icantly (Table 3). In contrast, at eight months and older,
severe cardiac enlargement and marked cardiac dysfunction
were evident. This late phenotype was associated with a
progressive increase in the left ventricular mass, decrease in
%FS, and increase in left ventricular end-diastolic dimen-
sion and left ventricular end-systolic dimension (Fig. 6).
DISCUSSION
In the present study, age-associated hypertrophy (ventricu-
lar remodeling) in Tg mice exhibited changes in ICa (21,22),
Ito density, and APDs. Barry et al. (25) and Wickenden et
al. (26) demonstrated the importance of Ito in controlling
the waveform of the mouse ventricular AP. These investi-
gators generated Tg mice using a dominant negative ap-
proach by over-expressing a pore mutant (Kv4.2W362F)
(lack of Ito,fast), (25) and Kv4.2N-HA, of Kv4.2 (decreased
Ito) (26), respectively. The APs in isolated ventricular
myocytes from these Tg mice were substantially broader
than from those of Ntg. However, hypertrophy was not
reported in the Kv4.2W362F Tg mice, despite the fact that
the functional knock-out of Ito increased the APD and
attenuated the density of Ito. On the contrary, the
Kv4.2N-HA Tg mice developed signs of hypertrophy,
albeit at older ages (4 months old).
Xu et al. (27), in the dominant-negative Kv2  subunit
mice, showed that IK,slow (slow component of the delayed
rectifier current) was selectively reduced and was associated
with a marked AP prolongation in ventricular myocytes;
however, no signs of hypertrophy were observed. It is
apparent that removal of Kv4- and Kv2-mediated currents
(Ito) do not pari passu result in cardiac hypertrophy.
In contrast to a number of models of cardiac hypertrophy
previously documented in which there is a down-regulation
of Ito and IK1, we observed a modest, though surprising,
increase in Ito,peak, Isus, and Ito up to eight months of age in
our Tg model of cardiac hypertrophy. Furthermore, our data
regarding Isus agree with previous results obtained from
calsequestrin over-expressed Tg mice (1). A variety of
factors have been suggested to account for this phenome-
Table 2. Comparison of Electrophysiological Parameters in Ntg and Tg Mice
Parameters
2 Months 4 Months 8 Months >9 Months
Ntg Tg Ntg Tg Ntg Tg Ntg Tg
Capacitance (pF) 173.2  7.8 178.2  4.9 184.6  6.9 210  9.4* 185.2  8.6 215.7  9.4* 183.3  9.2 262.7  9.2*
Ito (40 mV),
pA/pF
15.3  0.8 17.9  0.7† 14.1  0.8 18.3  1.0† 10.5  0.9 14.2  0.9† 12.5  1.3 8.3  1.0*
Ito,p (40 mV), pA/pF 20.9  1.0 25.3  0.9† 19.9  1.1 25.6  1.3† 17.3  1.1 22.0  1.0† 20.3  1.7 18.2  0.9
Isus (40 mV), pA/pF 7.5  0.5 8.3  0.4 6.6  0.4 8.3  0.4* 6.5  0.4 8.05  0.6* 7.7  0.5 7.5  0.5
IK1 (140 mV), pA/pF 25.9  0.9 24.6  0.8 23.3  0.8 23.7  1.1 18.1  0.9 21.8  1.0 22.1  1.0 18.2  0.7*
Inact. decay Ito fast (40 mV),
ms
– – 30.9  1.2 36.2  0.7 – – 49.0  2.5 55.9  2.3
Inact. decay Ito slow (40 mV),
ms
– – 315.7  25.5 365.5  26.2 – – 580.8  80.3 938.7  123.5*
Rec. Inact. Ito fast, ms – – 25.3  2.6 27.7  2.4 – – 21.9  1.9 30.7  3.3
Rec. Inact. Ito slow, ms – – 351.3  30.7 383.1  42.7 – – 237.9  16.2 491.2  34.8*
Inact. Ito V0.5, mV – – 23.9  2.0 19.5  0.8 – – 17.9  1.2 17.8  1.5
Inact. Ito k, mV – – 7.3  0.3 6.5  0.3 – – 6.4  0.2 6.9  0.2
*p  0.05; †p  0.001.
IK1  inward rectifier potassium current; Ito  transient outward potassium current; Ntg  nontransgenic; Rec. Inact.  recovery from inactivation; Tg  transgenic; Isus 
the current remaining at the end of the 680 ms pulse; fast  fast time constant of Ito inactivation or Ito recovery from inactivation; slow  slow time constant of Ito inactivation
or Ito recovery from inactivation.
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Figure 3. Voltage-dependent activation of Ito in mouse ventricular myocytes. Plots showing the voltage-dependence of the current density of Ito,peak at 2-,
4-, 8-, and 9- to 12-month-old cardiomyocytes (A) and Ito,peak-Isus (B). Families of Ito from 4-month-old Ntg (D) and Tg (E, F) myocytes were recorded
during a series of voltage clamps from a holding potential of 40 mV to selected test potentials ranging from 40 mV to 80 mV (C).
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non, but the mechanisms are still unclear (28). We offer the
speculation that the slight Ito up-regulation may provide a
protecting “balance mechanism” to obtund excessive length-
ening of the APD and Ca2 flux, in order to minimize the
incidence or onset of fatal ventricular arrhythmias.
Our data on Ito and ICa (21) provide important but
opposing roles in the prolongation of the APD. The
changes in Ito,peak and Isus (up to eight months of age)
should contribute to a shortening of APD and, indeed, we
observed perhaps a slight decrease or no change in APD in
the two-, four-, and eight-month-old Tg cardiac myocytes.
One must consider that the altered expression of Ca2-
handling proteins plays a significant role in prolongation of
APD, and the relationship between APD and Ito,fast is
multifactorial and complicated, at least according to model
studies (29). Prolonged APD in human ventricular myo-
cytes from patients with HF (30) may theoretically cause a
slowed diastolic decline of [Ca2]i and a reduced Ca
2
sequestration by the sarcoplasmic reticulum, thereby elevat-
ing diastolic Ca2. In our experiments, the APD was
slightly decreased in cardiac myocytes, recorded from four-
month-old Tg mice. One possibility to account for this
change is that an acceleration of [Ca2]i reuptake occurs,
which should increase the sarcoplasmic reticulum calcium
load and, thus, augment systolic myocardial function
(20,23). Indeed, this hypothesis was supported by Song et
al. (22) who found an enhanced rate of Ca2 transient decay
in our four-month-old Tg mice. A logical explanation for
the APD prolongation at the end stage of HF could be
enhanced ICa (21,22), Na
-Ca2 exchanger (NCX) (22)
Figure 4. Steady-state inactivation of Ito and ICa and inactivation properties of Ito in myocytes from 9- to 12-month-old nontransgenic (Ntg) and transgenic
(Tg) mice. Representative current tracings for voltage-dependence of steady-state inactivation of Ito are displayed from Ntg and Tg cardiac myocytes (A,
right panel). Voltage dependence of Ito inactivation was assessed using a double-pulse-protocol (A, left panel). The data are normalized to the largest peak
Ito and ICa currents measured using a prepulse of 100 mV versus 80 mV (Ito/Imax or ICa/Imax). The total peak outward current includes a steady-state
component that may not represent Ito. Data were fit to Boltzmann equation as follows: I  Imax/1exp (Vm-V0.5)/k, where I is recorded current, Imax is
maximum current, Vm is membrane potential, V0.5 is potential where inactivation is 50%, and k is the slope factor. Mean voltage-dependent inactivation
curve of ICa for Ntg and Tg myocytes, respectively (B). Inactivation decay courses of Ito recorded during 680 ms depolarizing voltage steps to test potential
40 mV. The time courses were determined in individual Ntg and Tg cells (9- to 12-month-old) using the double exponential fits (using the Chebyshev
algorithm of CLAMPFIT) to the decay phases of the currents (C and D) by the equation I(t)  Afast[exp(t/fast]  Aslow[exp(t/slow)]  A: Afast and
Aslow being the maximal amplitude; fast and slow being the time constants of the fast and slow components of inactivation, respectively. Time zero was
set next to the peak of the outward current. C and D show the fast and slow components of Ito inactivation at different depolarization potentials in Ntg
and Tg cardiac myocytes. Continued on next page.
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and down-regulation of Ito. Moreover, the protein expres-
sion level of Kv4.2 (underlying the cardiac Ito,fast) decreased
at the advanced ages.
The NCX also plays an important role in Ca2 ho-
meostasis in mouse heart (31), and an increase in its forward
mode of exchange might be expected to decrease contrac-
tility. We observed, however, an increased basal contractility
in the four-month-old Tg mice, and the NCX activity was
up-regulated (22). Less information is available concerning
the reverse mode of exchange via the NCX, but we cannot
rule out the role in “Ca2 overload,” which is thought to
lead to arrhythmias.
In the fetal mouse ventricle, the contribution of the
predominant Kv1.4 subunit to Ito,slow has been confirmed in
Kv1.4 knockout mice (32), and in animals generated by
crossbreeding the Kv4.2 (W362F) and the Kv1.4/ mice
(33). The fetal Kv1.4 subunit disappears in the adult, but we
have now documented its “reappearance” during the hyper-
trophy process. Guo et al. (33) and Wickenden et al. (34)
suggest that the up-regulation of Kv1.4  subunit (and
Ito,slow) is a “protective mechanism” against arrhythmogen-
esis. We feel that such a process occurs in the present mouse
model. We found a correlation between slow recovery
kinetics of Ito and an elevation in Kv1.4 protein levels in the
Tg model. We did not observe differences in the steady-
state inactivation of Ito between Tg and Ntg; therefore, the
slight up-regulation in Ito density in the Tg myocytes
appears to be due to an increased number of functional K
channels.
Our results also revealed an occurrence of EADs in phase
2 of the AP from eight-month-old Tg myocytes after
application of the non-specific K channel blocker 4-AP.
This is quite important. It has been suggested that L-type
ICa and NCX current are candidate inward currents for
initiating arrhythmia-triggering EAD in electrically remod-
eled myocardium (35); however, the precise molecular
mechanism, responsible for the EAD generation, has not
been defined and/or is controversial (36,37).
Study limitations. Gender differences and regional differ-
ences in current densities of myocytes are well known, but,
at this time, we did not take these parameters into consid-
eration.
Conclusions. Taken together, our electrophysiologic find-
ings show that the sustained, increased ingress of Ca2
(21,22) initiates a hypertrophy gene program in a very slow,
but progressive manner leading eventually from hypertrophy
to HF. We suggest that the progression of the disease is
accompanied by electrophysiologic remodeling. To recapit-
ulate, we observed an up-regulation of the Ito with no
change in APD during the development of compensatory
Figure 4 Continued. (E and F) Superimposed original current recordings showing time-course of recovery from inactivation of Ito in Ntg and Tg cells.
Capacitive transients were partially removed for clarity. (G) Plots showing reactivation of Ito in Ntg and Tg myocytes. Both curves were well-fitted by double
exponential function.
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Figure 5. Representative Western blots showing densities of Kv1.4, Kv4.2, and Kv4.3 proteins (A). GAPDH was used as internal control to normalize for
differences in loading. Samples were done in duplicates. Histogram depicting levels of Kv1.4 protein levels normalized to GAPDH in 2-, 4-, and
8-month-old transgenic (Tg) and nontransgenic (Ntg) ventricular membrane fractions (B).   Ntg;   Tg.
Table 3. Echocardiographic and Hemodynamic Parameters Are Summarized for 4-, 8-, and 9- to 12-Month-Old Ntg and Tg Mice
4-Month-Old 8-Month-Old 9- to 12-Month-Old
Ntg Tg-1OE Ntg Tg-1OE Ntg Tg-1OE
FS, % 50.4  1.9 43.6  2.6 47.4  2.3 31.7  2.8†
ESD, mm 1.4  0.09 1.7  0.11 1.6  0.08 2.8  0.23†
EDD, mm 2.8  0.12 3.0  0.08 2.9  0.05 4.0  0.17†
AWT, mm 0.62  0.02 0.65  0.03 0.62  0.03 0.62  0.02
PWT, mm 0.61  0.01 0.63  0.02 0.65  0.03 0.64  0.02
h/r (PWT/EDD-2) 0.44  0.01 0.43  0.02 0.43  0.02 0.32  0.02†
LVM, mg 47.7  4.5 54.6  3.9 52.8  4.4 87.2  6.1†
HR, beats/min 677.1  28.3 591.4  28.3* 690.0  14.1 522.4  12.4†
E time, ms 40.3  0.81 44.1  0.96* 38.4  1.1 49.1  1.6†
Vcf, circ/s 12.6  0.62 9.9  0.65* 12.4  0.66 6.7  0.65†
n (mice studied) 7 7 9 17
Contraction properties:
dP/dt, mm Hg/s 3,836.7  147 5,012  225* 3,418  149 3,903  183* 4,010  412 2,265  439*
TPP, ms/mm Hg 0.46  0.03 0.37  0.02 0.42  0.01 0.41  0.02 0.37  0.03 1.0  0.24*
Relaxation parameters:
dP/dt, mm Hg/s 2,922  158 2,818  108 2,744  179 2,080  141* 3,085  373 1,353  191†
RT1⁄2, ms/mm Hg 0.74  0.05 0.75  0.07 0.66  0.04 0.91  0.09* 0.55  0.08 1.2  0.03†
n (mice studied) 6 6 5 4 4 4
*p  0.05 vs. Ntg; †p  0.001 vs. Ntg.
AWT  anterior wall thickness; dP/dt  maximal rate of left ventricular pressure development; dP/dt  maximal rate of left ventricular decline; EDD  end-diastolic
dimension; ESD  end-systolic dimension; E time  ejection time; FS  fractional shortening; HR  heart rate; LVM  left ventricular mass; Ntg  nontransgenic; PWT
 posterior wall thickness; R/T1⁄2  time to half-relaxation; Tg  transgenic; TPP  time to peak pressure; Vcf  mean velocity of circumferential fiber shortening.
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cardiac hypertrophy in the Tg mice up to eight months of
age. Decreased Ito was associated with APD prolongation in
the failing stage of cellular phenotypes with left ventricular
dysfunction, from 9- to 12-month-old Tg mice.
These results can be considered as one case of partial
uncoupling of electrophysiologic and structural remodeling
in hypertrophy (38).
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